8-K: AdaptHealth Corp. Amends Separation Agreement with Chief Business Officer, Shaw Rietkerk
8-K Filing
AdaptHealth Corp. has amended its separation agreement with Chief Business Officer Shaw Rietkerk, reducing his annual base salary to $125,000 from January 1, 2025, until his separation date.
Summary
- AdaptHealth Corp. has amended its transition, separation, and release agreement with Chief Business Officer Shaw Rietkerk.
- The amendment, effective December 9, 2024, reduces Mr. Rietkerk's annual base salary from $500,000 to $125,000.
- This salary reduction will be effective from January 1, 2025, until his separation date of March 31, 2025.
- All other terms of the original transition and separation agreement remain unchanged.
Sentiment
Score: 6
Explanation: The document is neutral in tone, detailing a planned change in executive compensation. It is not particularly positive or negative, but rather a procedural update.
Future Outlook
The amended agreement outlines the terms of Shaw Rietkerk's compensation until his separation date on March 31, 2025.
Management Comments
- The amendment confirms the agreement between AdaptHealth Corp. and Shaw Rietkerk regarding the change in annual base pay.
- Suzanne Foster, Chief Executive Officer of AdaptHealth Corp., signed the amendment on behalf of the company.
Industry Context
Changes in executive compensation and separation agreements are common in corporate settings, particularly during transitions. This filing provides transparency regarding the terms of Mr. Rietkerk's departure.
Comparison to Industry Standards
- Executive compensation packages vary widely across the healthcare industry, but it is common for companies to adjust compensation during transition periods.
- Comparable companies in the healthcare services sector often have similar agreements in place for departing executives, including adjustments to base salary and other benefits.
- The specific terms of this agreement, such as the reduction in base salary, are likely tailored to the individual circumstances of Mr. Rietkerk's departure and the company's financial considerations.
Stakeholder Impact
- Shareholders are informed of the changes in executive compensation.
- Employees may be aware of the changes in leadership and compensation.
Key Dates
| Date | Description |
|---|---|
| 2024-08-21 | Original transition and separation agreement date. |
| 2024-12-09 | Date of the amendment to the transition, separation, and release agreement. |
| 2024-12-13 | Date of the 8-K filing. |
| 2025-01-01 | Effective date of the salary reduction. |
| 2025-03-31 | Shaw Rietkerk's separation date. |
Keywords
AdaptHealth, Shaw Rietkerk, separation agreement, executive compensation, salary reduction, Chief Business Officer, transition agreement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.